TruNativ, a direct-to-consumer nutrition brand, raised $30 million (₹290 crore) in a Series B funding round led by US-based investor OrbiMed. The round included both primary and secondary transactions and saw participation from existing investors such as 100Unicorns, Rainmatter, and Venture Catalysts. The startup plans to use the capital to boost its offline retail presence across Tier I and II cities and expand into new segments.
Founded in 2019 by Mamta and Pranav Malhotra along with Eeshaan Merchant, TruNativ sells nutrition products including protein and fiber sachets and a natural monk fruit sweetener, its top-selling item. The Series B round diluted FMCG major Emami’s stake from 19% to 10%. The company intends to partner with leading supermarket chains and explore opportunities in the hotel, restaurant, and catering (HORECA) sector as well as the D2C segment. It also plans to launch an innovation centre called “The Good Lab” in Mumbai to enhance research and development.
The fresh funding will support TruNativ’s expansion into new product categories such as collagen supplements, water-soluble proteins, and other macro-nutrient supplements. The startup recorded ₹130 crore in revenue in fiscal year 2026, marking a 35% growth. The move to strengthen offline distribution aligns with trends where nutrition brands are increasingly focusing on omnichannel presence to capture a wider consumer base. TruNativ’s approach of combining everyday cooking supplements with natural ingredients positions it distinctively in the growing health and wellness market.
TruNativ’s next steps include scaling partnerships with supermarket chains and entering the HORECA segment, supported by the $30 million funding. The launch of “The Good Lab” innovation centre in Mumbai is expected to advance product development and innovation in the supplement space, according to cofounder and CEO Pranav Malhotra.